170 related articles for article (PubMed ID: 19596920)
1. Doxorubicin and congo red effectiveness on prion infectivity in golden Syrian hamster.
Corato M; Ogliari P; Ceciliani F; Cova E; Bellotti V; Cereda C; Merlini G; Ceroni M
Anticancer Res; 2009 Jul; 29(7):2507-12. PubMed ID: 19596920
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of analogues of Congo red and evaluation of their anti-prion activity.
Sellarajah S; Lekishvili T; Bowring C; Thompsett AR; Rudyk H; Birkett CR; Brown DR; Gilbert IH
J Med Chem; 2004 Oct; 47(22):5515-34. PubMed ID: 15481988
[TBL] [Abstract][Full Text] [Related]
4. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases.
Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS
J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066
[TBL] [Abstract][Full Text] [Related]
5. Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein.
Wille H; Prusiner SB; Cohen FE
J Struct Biol; 2000 Jun; 130(2-3):323-38. PubMed ID: 10940236
[TBL] [Abstract][Full Text] [Related]
6. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
7. The anti-prion activity of Congo red. Putative mechanism.
Caspi S; Halimi M; Yanai A; Sasson SB; Taraboulos A; Gabizon R
J Biol Chem; 1998 Feb; 273(6):3484-9. PubMed ID: 9452472
[TBL] [Abstract][Full Text] [Related]
8. Congo red analogues as potential anti-prion agents.
Villa S; Cignarella G; Barlocco D; Gervasoni M; Carcassola G; Giannino L; Mantegazza P
Farmaco; 2003 Sep; 58(9):929-37. PubMed ID: 13679188
[TBL] [Abstract][Full Text] [Related]
9. Effect of Congo red on wild-type and mutated prion proteins in cultured cells.
Milhavet O; Mangé A; Casanova D; Lehmann S
J Neurochem; 2000 Jan; 74(1):222-30. PubMed ID: 10617123
[TBL] [Abstract][Full Text] [Related]
10. Congo red prolongs the incubation period in scrapie-infected hamsters.
Ingrosso L; Ladogana A; Pocchiari M
J Virol; 1995 Jan; 69(1):506-8. PubMed ID: 7983747
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of anthracycline against experimental prion disease in Syrian hamsters.
Tagliavini F; McArthur RA; Canciani B; Giaccone G; Porro M; Bugiani M; Lievens PM; Bugiani O; Peri E; Dall'Ara P; Rocchi M; Poli G; Forloni G; Bandiera T; Varasi M; Suarato A; Cassutti P; Cervini MA; Lansen J; Salmona M; Post C
Science; 1997 May; 276(5315):1119-22. PubMed ID: 9148807
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of anti-prion activity of congo red and its derivatives in experimentally infected hamsters.
Poli G; Martino PA; Villa S; Carcassola G; Giannino ML; Dall'Ara P; Pollera C; Iussich S; Tranquillo VM; Bareggi S; Mantegazza P; Ponti W
Arzneimittelforschung; 2004; 54(7):406-15. PubMed ID: 15344846
[TBL] [Abstract][Full Text] [Related]
13. Inoculation of scrapie with the self-assembling RADA-peptide disrupts prion accumulation and extends hamster survival.
Hnasko R; Bruederle CE
PLoS One; 2009; 4(2):e4440. PubMed ID: 19212437
[TBL] [Abstract][Full Text] [Related]
14. Congo red and protein aggregation in neurodegenerative diseases.
Frid P; Anisimov SV; Popovic N
Brain Res Rev; 2007 Jan; 53(1):135-60. PubMed ID: 16959325
[TBL] [Abstract][Full Text] [Related]
15. The effect of Fenton reaction on protease-resistant prion protein (PrPSc) degradation and scrapie infectivity.
Park SJ; Kim NH; Jeong BH; Jin JK; Choi JK; Park YJ; Kim JI; Carp RI; Kim YS
Brain Res; 2008 Oct; 1238():172-80. PubMed ID: 18771660
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of scrapie-associated PrP accumulation by congo red.
Caughey B; Race RE
J Neurochem; 1992 Aug; 59(2):768-71. PubMed ID: 1352803
[TBL] [Abstract][Full Text] [Related]
17. ST1859 reduces prion infectivity and increase survival in experimental scrapie.
Colombo L; Piovesan P; Ghirardi O; Salmona M; Forloni G
Arch Virol; 2009; 154(9):1539-44. PubMed ID: 19685199
[TBL] [Abstract][Full Text] [Related]
18. Prion urine comprises a glycosaminoglycan-light chain IgG complex that can be stained by Congo red.
Halimi M; Dayan-Amouyal Y; Kariv-Inbal Z; Friedman-Levi Y; Mayer-Sonnenfeld T; Gabizon R
J Virol Methods; 2006 May; 133(2):205-10. PubMed ID: 16386805
[TBL] [Abstract][Full Text] [Related]
19. Congo red inhibition of scrapie agent replication.
Caughey B; Ernst D; Race RE
J Virol; 1993 Oct; 67(10):6270-2. PubMed ID: 8103804
[TBL] [Abstract][Full Text] [Related]
20. Prion inhibition with multivalent PrPSc binding compounds.
Mays CE; Joy S; Li L; Yu L; Genovesi S; West FG; Westaway D
Biomaterials; 2012 Oct; 33(28):6808-22. PubMed ID: 22748770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
